Researchers analysed clinical, biochemical, and continuous glucose monitoring data from 2,491 adults aged 60 years or older with Type 2 diabetes.
Continuous glucose monitoring in older adults reveals distinct metabolic phenotypes that link high glucose exposure with advanced cardiovascular-kidney-metabolic syndrome, according to a study published in the Journal of Diabetes.
The research, led by Hang Su and colleagues at Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, challenges standard assumptions about glycemic control by showing that stable, high blood sugar patterns carry a heavier cardiorenal toll than fluctuating ones.
- Continuous Glucose Monitors (CGMs): Wearable medical devices that track interstitial glucose levels every few minutes to reveal hidden blood sugar spikes and drops.
- Time Above Range (TAR): The percentage of time a patient’s blood glucose stays above the safe target upper limit.
- Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A systemic disorder defined by the American Heart Association linking heart disease, chronic kidney disease, and metabolic risk factors like diabetes.
Researchers analysed clinical, biochemical, and continuous glucose monitoring data from 2,491 adults aged 60 years or older with Type 2 diabetes. For the three months prior, subjects had kept their glucose-lowering medications unchanged, and they then completed a week of blinded CGM assessment. Cardiovascular-kidney-metabolic syndrome was classified according to American Heart Association criteria, with Stages 3 and 4 considered advanced disease. Overall, 65.0% of participants had advanced disease.
Based on whether their time above range and mean amplitude of glycemic excursions metrics sat above or below the cohort’s respective median thresholds of 27.0% and 5.3 mmol/L, the individuals were sorted into four distinct categories.
Participants with both high time above range and high mean amplitude of glycemic excursions had the poorest overall glycemic control, including the highest median HbA1c of 9.1% and the lowest time in range. However, the high time above range and low mean amplitude of glycemic excursions phenotype showed the highest prevalence of advanced cardiovascular-kidney-metabolic syndrome, at 73.3%, with an odds ratio of 1.62.
| Glycemic Phenotype | Median HbA1c | Advanced CKM Prevalence |
|---|---|---|
| High TAR / High MAGE | 9.1% | Lower than high TAR / low MAGE |
| High TAR / Low MAGE | Lower | 73.3% |
| Overall Population (2,491 adults) | Not reported | 65.0% |
This group demonstrated a fasting hyperglycaemia-dominant pattern, featuring the highest fasting plasma glucose and triglyceride levels alongside the lowest insulin sensitivity among the four groups. Researchers suggested that continuous glucose monitoring-derived phenotypes may help characterise metabolic heterogeneity that is not fully captured by conventional glycaemic indicators.
- Su H, Ni J, Cai J, et al. Continuous Glucose Monitoring-Derived Glycemic Phenotypes Reflect Metabolic Heterogeneity Linked to Advanced Cardiovascular-Kidney-Metabolic Syndrome in Older Adults With Type 2 Diabetes. Journal of Diabetes. 2026. DOI: 10.1111/1753-0407.70298
- Glucose Patterns Reveal Metabolic Differences in Adults with Type 2 Diabetes.